Oncotarget

Vol 11, No 43

October 27, 2020

View Archive »

Order a Reprint

About The Cover

The cover for issue 43 of Oncotarget features Figure 6, "(A) Following the experimental protocol of Franzetti et al. [11] A673-shA1c cells −/+ Dox (EWS/Fli1high/EWS/Fli1low) were injected into the tail vein, and metastases were allowed to form in the absence of further Dox treatment (to allow recovery of cell growth in EWS/Fli1low cells)," by McCann, et al.

Table of Contents

Research Papers

Significance of mesothelin expression in preoperative endoscopic biopsy specimens for colorectal cancer prognosis

Significance of mesothelin expression in preoperative endoscopic biopsy specimens for colorectal cancer prognosis

https://doi.org/10.18632/oncotarget.27774

Takehiro Shiraishi, Eiji Shinto, Masato Yamadera, Ken Nagata, Hitoshi Tsuda, Satsuki Mochizuki, Yoshiki Kajiwara, Koichi Okamoto, Takahiro Einama, Yoji Kishi,  and Hideki Ueno
3807-3817
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite  |  Order a Reprint

KDM5A and PHF2 positively control expression of pro-metastatic genes repressed by EWS/Fli1, and promote growth and metastatic properties in Ewing sarcoma

KDM5A and PHF2 positively control expression of pro-metastatic genes repressed by EWS/Fli1, and promote growth and metastatic properties in Ewing sarcoma

https://doi.org/10.18632/oncotarget.27737

Tyler S. McCann, Janet K. Parrish, Joseph Hsieh, Marybeth Sechler, Lays M. Sobral, Chelsea Self, Kenneth L. Jones, Andrew Goodspeed, James C. Costello,  and Paul Jedlicka
3818-3831
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite  |  Press Release  |  Order a Reprint

Regulation of breast cancer oncogenesis by the cell of origin’s differentiation state

Regulation of breast cancer oncogenesis by the cell of origin’s differentiation state

https://doi.org/10.18632/oncotarget.27783

Sarah C. Petrova, Ihsaan Ahmad, Christine Nguyen, Stuart D. Ferrell Jr, Sabrina R. Wilhelm, Yin Ye,  and Sanford H. Barsky
3832-3848
Abstract  |  PDF  |  Full Text  |  How to cite  |  Order a Reprint

Predictive biomarkers for sacituzumab govitecan efficacy in Trop-2-expressing triple-negative breast cancer

Predictive biomarkers for sacituzumab govitecan efficacy in Trop-2-expressing triple-negative breast cancer

https://doi.org/10.18632/oncotarget.27766

Thomas M. Cardillo, Diane L. Rossi, Maria B. Zalath, Donglin Liu, Roberto Arrojo, Robert M. Sharkey, Chien-Hsing Chang,  and David M. Goldenberg
3849-3862
Abstract  |  PDF  |  Full Text  |  How to cite  |  Press Release  |  Order a Reprint

Targeting breast cancer metabolism with a novel inhibitor of mitochondrial ATP synthesis

Targeting breast cancer metabolism with a novel inhibitor of mitochondrial ATP synthesis

https://doi.org/10.18632/oncotarget.27743

Myoung Sook Kim, Ramkishore Gernapudi, Yessenia Cedeño Cedeño, Brian M. Polster, Ramon Martinez, Paul Shapiro, Santosh Kesari, Elmar Nurmemmedov,  and Antonino Passaniti
3863-3885
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite  |  Press Release  |  Order a Reprint

Heterogeneity of CEACAM5 in breast cancer

Heterogeneity of CEACAM5 in breast cancer

https://doi.org/10.18632/oncotarget.27778

Marc B. Bechmann, Andreas V. Brydholm, Victoria L. Codony, Jiyoung Kim,  and René Villadsen
3886-3899
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite  |  Press Release  |  Order a Reprint


Copyright © 2020 Impact Journals, LLC
Impact Journals is a registered trademark of Impact Journals, LLC